AGENCY: Department of Energy.
ACTION: Notice of open meeting.
SUMMARY: This notice announces a meeting of the Environmental Management Advisory Board (EMAB). The Federal Advisory Committee Act (Pub. L. 92-463, 86 Stat. 770) requires that public notice of this meeting be announced in the Federal Register.
DATES: Thursday, May 22, 2014 9:30 a.m.-4:30 p.m.
ADDRESSES: Pacific Northwest National Laboratory, 902 Battelle Boulevard, Richland, Washington 99354.
FOR FURTHER INFORMATION CONTACT: Kristen G. Ellis, Designated Federal Officer, EMAB (EM-3.2), U.S. Department of Energy, 1000 Independence Avenue SW., Washington, DC 20585. Phone (202) 586-5810; fax (202) 586- 0293 or email: firstname.lastname@example.org.
AGENCY: Environmental Protection Agency (EPA).
SUMMARY: The Environmental Protection Agency (EPA) announces a public meeting of the Great Lakes Advisory Board (Board). The purpose of this meeting is to address administrative matters and discuss further advice to strengthen the effectiveness of the Great Lakes Restoration Initiative (GLRI).
DATES: The public meeting will be held on Wednesday, May 28, 2014 from 10:00 a.m. to 4:00 p.m. Central Time, 11:00 a.m. to 5:00 p.m. Eastern Time. An opportunity will be provided to the public to comment.
ADDRESSES: The public meeting will be held at the EPA Region 5 Offices, Lake Michigan Room, twelfth floor, in the Ralph H. Metcalfe Federal Building, 77 W. Jackson Boulevard, Chicago, Illinois, 60604. The teleconference number is: (877) 744-6030; Participant code: 24658751.
FOR FURTHER INFORMATION CONTACT: Any member of the public wishing further information regarding this meeting may contact Taylor Fiscus, Acting Designated Federal Officer (DFO), by telephone at 312-353-6059 or email at Fiscus.Taylor@epa.gov. General information on the GLRI and the Board can be found at http://www.glri.us.
SUMMARY: The Center for Scientific Review (CSR) is seeking ideas for the detection of bias in NIH Peer Review of grant applications in a challenge titled "New Methods to Detect Bias in Peer Review.'' This notice provides information regarding requirements and registration for this challenge.
Submission Period: May 5, 2014 through 11:59 p.m. Eastern Time, June 30, 2014.
Judging Period: July 16, 2014 through August 29, 2014.
Winners Announced: September 2, 2014.
ADDRESSES: Details on the NIH/CSR Peer Review process can be found on the Reviewer Resources tab at www.csr.nih.gov. For questions about this challenge, email CSRDiversityPeerRev@mail.nih.gov or call at 301-300-3839.
FOR FURTHER INFORMATION CONTACT: Monica Basco, Center for Scientific Review, phone: 301-300-3839 or email: CSRDiversityPeerRev@mail.nih.gov.
SUMMARY: The National Institutes of Health (NIH) Center for Scientific Review (CSR) is issuing a challenge titled "Strategies to Strengthen Fairness and Impartiality in Peer Review.'' This notice provides information regarding requirements and registration for the challenge.
DATES: Submission Period: May 5, 2014 through 11:59 p.m. Eastern Time, June 30, 2014.
Judging Period: July 16, 2014 through August 29, 2014.
Winners Announced: September 2, 2014.
ADDRESSES: Details on the NIH/CSR Peer Review process and current reviewer training materials can be found on the Reviewer Resources tab at www.csr.nih.gov (See NIH Peer Review Process Revealed and Resources for Reviewers). For questions about this challenge, please contact CSRDiversityPeerRev@mail.nih.gov or call at 301-300-3839.
FOR FURTHER INFORMATION CONTACT: Monica Basco, Center for Scientific Review, phone: 301-300-3839 or email at CSRDiversityPeerRev@mail.nih.gov.
SUMMARY: The National Institutes of Health (NIH) will hold a teleconference with interested stakeholders to gather perspectives on issues related to the enrollment and retention of research participants in NIH-funded clinical trials. The stakeholder input will inform the planning of an NIH workshop on this topic that will be scheduled this summer.
DATES: May 16, 2014, from 3:00 p.m.-4:30 p.m., ET.
ADDRESSES: The meeting will be held by teleconference. A teleconference agenda and logistical information will be posted in advance of the teleconference at the following Web site: http://osp.od.nih.gov/.
FOR FURTHER INFORMATION CONTACT: Valery Gordon, Ph.D., Acting Director, Clinical Research Program, Office of Science Policy, NIH; email: email@example.com; telephone: 301-496-9838.
AGENCY: Food and Drug Administration, HHS.
This notice announces a forthcoming meeting of a public advisory committee of the Food and Drug Administration (FDA). The meeting will be open to the public.
Name of Committee: Science Board to the Food and Drug Administration (Science Board).
General Function of the Committee: The Science Board provides advice primarily to the Commissioner of Food and Drugs and other appropriate officials on specific complex scientific and technical issues important to FDA and its mission, including emerging issues within the scientific community. Additionally, the Science Board provides advice to the Agency on keeping pace with technical and scientific developments including those in regulatory science; and input into the Agency's research agenda; and on upgrading its scientific and research facilities and training opportunities. It will also provide, where requested, expert review of Agency sponsored intramural and extramural scientific research programs.
Date and Time: The meeting will be held on June 4, 2014, from approximately 8:30 a.m. until 4:30 p.m.
Location: FDA White Oak Campus, 10903 New Hampshire Ave., Bldg. 31 Conference Center, the Great Room (Rm. 1503, sections B and C), Silver Spring, MD 20993. Information regarding special accommodations due to a disability, visitor parking, and transportation may be accessed at: http://www.fda.gov/AdvisoryCommittees/default.htm; under the heading "Resources for You,'' click on "Public Meetings at the FDA White Oak Campus.'' Please note that visitors to the White Oak Campus must enter through Building 1.
Contact Person: Martha Monser, Office of the Chief Scientist, Office of the Commissioner, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, Rm. 4286, Silver Spring, MD 20993, 301-796- 4627, firstname.lastname@example.org, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area). A notice in the Federal Register about last minute modifications that impact a previously announced advisory committee meeting cannot always be published quickly enough to provide timely notice. Therefore, you should always check the Agency's Web site at http://www.fda.gov/AdvisoryCommittees/default.htm and scroll down to the appropriate advisory committee meeting link, or call the advisory committee information line to learn about possible modifications before coming to the meeting.
Agenda: On June, 4, 2014, the Science Board will discuss and make recommendations on the draft final report from the Center for Biologics Evaluation and Research's postmarketing safety review subcommittee. The committee will be asked to support forming a new subcommittee to evaluate the Commissioner's Fellowship Program. The committee will be presented with an overview of current issues surrounding heparin sourcing issues for discussion. A recipient of one of the fiscal year 2013 Scientific Achievement Awards (selected by the Science Board) will provide an overview of the activities for which the award was given.
FDA intends to make background material available to the public no later than 2 business days before the meeting. If FDA is unable to post the background material on its Web site prior to the meeting, the background material will be made publicly available at the location of the advisory committee meeting, and the background material will be posted on FDA's Web site after the meeting. Background material is available at http://www.fda.gov/AdvisoryCommittees/Calendar/default.htm. Scroll down to the appropriate advisory committee meeting link.
Procedure: Interested persons may present data, information, or views, orally or in writing, on issues pending before the committee. Written submissions may be made to the contact person on or before May 28, 2014. Oral presentations from the public will be scheduled between approximately 3 p.m. and 4 p.m. Those individuals interested in making formal oral presentations should notify the contact person and submit a brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time requested to make their presentation on or before May 20, 2014. Time allotted for each presentation may be limited. If the number of registrants requesting to speak is greater than can be reasonably accommodated during the scheduled open public hearing session, FDA may conduct a lottery to determine the speakers for the scheduled open public hearing session. The contact person will notify interested persons regarding their request to speak by May 21, 2014.
Persons attending FDA's advisory committee meetings are advised that the Agency is not responsible for providing access to electrical outlets.
FDA welcomes the attendance of the public at its advisory committee meetings and will make every effort to accommodate persons with physical disabilities or special needs. If you require special accommodations due to a disability, please contact Martha Monser at least 7 days in advance of the meeting.
FDA is committed to the orderly conduct of its advisory committee meetings. Please visit our Web site at http://www.fda.gov/AdvisoryCommittees/AboutAdvisoryCommittees/ucm111462.htm for procedures on public conduct during advisory committee meetings.
Notice of this meeting is given under the Federal Advisory Committee Act (5 U.S.C. app. 2).
AGENCY: Office of Science, Department of Energy.
ACTION: Notice of Open Teleconference.
SUMMARY: This notice sets forth the schedule and summary agenda for a conference call of the President's Council of Advisors on Science and Technology (PCAST) and describes the functions of the Council. Notice of this meeting is required under the Federal Advisory Committee Act (FACA), 5 U.S.C., App. 2. The purpose of this conference call is to discuss PCAST's antimicrobial resistance report and advanced manufacturing reports.
DATES: The public conference call will be held on Wednesday, May 28, 2014 from 3:00 p.m. to 4:00 p.m., Eastern Time (ET). To receive the call-in information, attendees should register for the conference call on the PCAST Web site, http://www.whitehouse.gov/ostp/pcast no later than 12:00 p.m. ET on Friday, May 23, 2014.
FOR FURTHER INFORMATION CONTACT: Information regarding the call agenda, time, and how to register for the call is available on the PCAST Web site at: http://whitehouse.gov/ostp/pcast. Questions about the conference call should be directed to Dr. Ashley Predith, PCAST Assistant Executive Director, by email at: email@example.com, or telephone: (202) 456-4444.